Cancer type | Characteristic | Total (cases) | HR (95% CI) | P |
---|---|---|---|---|
BRCA | Age (years) | |||
 ≤ 60 | 96 | 1.000 |  | |
 > 60 | 49 | 1.467 (0.864–2.752) | 0.323 | |
TNBCa | ||||
 No | 109 | 1.000 |  | |
 Yes | 24 | 2.296 (1.169–4.508) | 0.016 | |
TNM stageb | ||||
 I/II | 95 | 1.000 |  | |
 III/IV | 48 | 2.296 (1.279–4.120) | 0.005 | |
PGK1 pS203 | ||||
 Low | 65 | 1.000 |  | |
 High | 80 | 1.905 (1.024–3.546) | 0.042 | |
PDHK1 pT338 | ||||
 Low | 66 | 1.000 |  | |
 High | 79 | 1.969 (1.058–3.665) | 0.032 | |
LIHC | Age (years) | |||
 ≤ 60 | 75 | 1.000 |  | |
 > 60 | 110 | 1.351 (0.863–1.962) | 0.527 | |
Gender | ||||
 Male | 159 | 1.000 |  | |
 Female | 26 | 0.597 (0.327–1.087) | 0.092 | |
TNM stagec | ||||
 I/II | 73 | 1.000 |  | |
 III/IV | 104 | 2.796 (1.848–4.229) | < 0.001 | |
PGK1 pS203 | ||||
 Low | 107 | 1.000 |  | |
 High | 78 | 1.909 (1.311–2.781) | 0.001 | |
PDHK1 pT338 | ||||
 Low | 105 | 1.000 |  | |
 High | 80 | 2.354 (1.610–3.441) | < 0.001 | |
LUAD | Age (years) | |||
 ≤ 60 | 84 | 1.000 |  | |
 > 60 | 95 | 1.339 (0.944–1.900) | 0.102 | |
Gender | ||||
 Male | 104 | 1.000 |  | |
 Female | 75 | 0.775 (0.542–1.107) | 0.162 | |
TNM stage | ||||
 I/II | 105 | 1.000 |  | |
 III/IV | 74 | 1.861 (1.309–2.647) | 0.001 | |
PGK1 pS203 | ||||
 Low | 74 | 1.000 |  | |
 High | 105 | 1.760 (1.221–2.537) | 0.002 | |
PDHK1 pT338 | ||||
 Low | 75 | 1.000 |  | |
 High | 104 | 1.595 (1.111–2.291) | 0.011 | |
STAD | Age (years) | |||
 ≤ 60 | 56 | 1.000 |  | |
 > 60 | 39 | 1.754 (1.144–2.689) | 0.010 | |
Gender | ||||
 Male | 60 | 1.000 |  | |
 Female | 35 | 1.017 (0.660–1.567) | 0.938 | |
TNM staged | ||||
 I/II | 24 | 1.000 |  | |
 III/IV | 69 | 2.590 (1.536–4.365) | < 0.001 | |
PGK1 pS203 | ||||
 Low | 51 | 1.000 |  | |
 High | 44 | 1.797 (1.173–2.752) | 0.007 | |
PDHK1 pT338 | ||||
 Low | 49 | 1.000 |  | |
 High | 46 | 1.694 (1.105–2.596) | 0.016 | |
ESCA | Age (years) | |||
 ≤ 60 | 112 | 1.000 |  | |
 > 60 | 102 | 1.869 (1.300–2.686) | 0.001 | |
Gender | ||||
 Male | 176 | 1.000 |  | |
 Female | 38 | 1.127 (0.709–1.789) | 0.614 | |
TNM stage | ||||
 I/II | 98 | 1.000 |  | |
 III/IV | 116 | 6.447 (4.139–10.043) | < 0.001 | |
PGK1 pS203 | ||||
 Low | 103 | 1.000 |  | |
 High | 111 | 1.669 (1.157–2.406) | 0.006 | |
PDHK1 pT338 | ||||
 Low | 94 | 1.000 |  | |
 High | 120 | 1.763 (1.213–2.563) | 0.003 |